LifeStance Beats Q3, Raises FY26 Revenue to $1.741B-$1.761B and EBITDA to $242M-$250M
LFST has more than doubled off its 52-week low of $4.79.
Summary
LifeStance beat on Q3 with revenue up 25% to $455.9 million and Adjusted EBITDA up 70% to $68.4 million, then raised full-year 2026 revenue and EBITDA guidance across the board.
Key Events · Earnings and Guidance · LFST
-
Q3 Revenue Up 25% to $455.9M
Revenue rose to $455.9 million from $363.8 million, driven by 11% clinician growth to 8,863 and 17% higher visit volumes of 2.7 million.
-
Adjusted EBITDA Jumped 70% to $68.4M
Adjusted EBITDA reached $68.4 million, or 15.0% of revenue, versus $40.2 million and 11.1% a year ago; net income was $22.4 million against $1.1 million.
-
FY26 Guidance Raised Across All Metrics
Revenue guidance lifted to $1.741-$1.761 billion from $1.685-$1.725 billion, Center Margin to $599-$613 million from $570-$594 million, and Adjusted EBITDA to $242-$250 million from $215-$235 million.
-
Q4 Outlook Set at $446M-$466M Revenue
Fourth-quarter guidance calls for revenue of $446-$466 million, Center Margin of $149-$163 million and Adjusted EBITDA of $56-$64 million, assuming 20 to 30 new center openings.
Analysis · LFST · Industrial Applications And Services
LifeStance delivered a quarter well ahead of last year and pulled its full-year targets up across every metric. Revenue rose 25% to $455.9 million while Adjusted EBITDA jumped 70% to $68.4 million, lifting the EBITDA margin from 11.1% to 15.0% — the operating leverage story is now showing up in the numbers, not just the narrative. Management raised FY26 revenue guidance to $1.741-$1.761 billion (from $1.685-$1.725 billion) and Adjusted EBITDA to $242-$250 million (from $215-$235 million), a meaningful mid-point lift on profitability. The company also generated $170.0 million of operating cash flow through nine months and bought back $122.4 million of stock, against $218.8 million of cash and $255.5 million of net long-term debt. With the stock already trading near its 52-week high, the raise validates the re-rating rather than creating a new one.
How filings like this one have moved
In the 30 days to Nov 6, 2026, 44.9% of the 1410 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LFST was trading at $14.98 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $4.79 to $14.31. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.